4//SEC Filing
Bozigian Haig P. 4
Accession 0001209191-20-029401
CIK 0000914475other
Filed
May 13, 8:00 PM ET
Accepted
May 14, 8:09 PM ET
Size
25.5 KB
Accession
0001209191-20-029401
Insider Transaction Report
Form 4
Bozigian Haig P.
Sr Vice President, Development
Transactions
- Exercise/Conversion
Common Stock
2020-05-12$35.99/sh+9,094$327,293→ 157,727 total - Sale
Common Stock
2020-05-12$114.94/sh−9,094$1,045,303→ 148,633 total - Exercise/Conversion
Common Stock
2020-05-12$43.24/sh+18,571$803,010→ 167,204 total - Sale
Common Stock
2020-05-12$114.94/sh−18,571$2,134,631→ 148,633 total - Exercise/Conversion
Common Stock
2020-05-12$81.49/sh+15,833$1,290,231→ 164,466 total - Sale
Common Stock
2020-05-12$114.94/sh−15,833$1,819,913→ 148,633 total - Exercise/Conversion
Common Stock
2020-05-12$81.05/sh+18,057$1,463,520→ 166,690 total - Sale
Common Stock
2020-05-12$114.94/sh−18,057$2,075,549→ 148,633 total - Exercise/Conversion
Non-Qualified Stock Option
2020-05-12−9,094→ 0 totalExercise: $35.99Exp: 2026-02-05→ Common Stock (9,094 underlying) - Exercise/Conversion
Non-Qualified Stock Option
2020-05-12−18,571→ 15,289 totalExercise: $43.24Exp: 2027-02-06→ Common Stock (18,571 underlying) - Exercise/Conversion
Non-Qualified Stock Option
2020-05-12−15,833→ 13,340 totalExercise: $81.49Exp: 2028-02-05→ Common Stock (15,833 underlying) - Exercise/Conversion
Non-Qualified Stock Option
2020-05-12−18,057→ 47,383 totalExercise: $81.05Exp: 2029-02-07→ Common Stock (18,057 underlying)
Footnotes (6)
- [F1]The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $112.43 to $117.58. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]Option granted February 05, 2016 and vested monthly over four years.
- [F4]Option granted February 06, 2017 and vests monthly over four years.
- [F5]Option granted February 05, 2018 and vests monthly over four years.
- [F6]Option granted February 07, 2019 and vests monthly over four years.
Documents
Issuer
NEUROCRINE BIOSCIENCES INC
CIK 0000914475
Entity typeother
Related Parties
1- filerCIK 0001423837
Filing Metadata
- Form type
- 4
- Filed
- May 13, 8:00 PM ET
- Accepted
- May 14, 8:09 PM ET
- Size
- 25.5 KB